Netanyahu's Assignment of Blame for Teen Deaths Cast Into Doubt
Truthdigger of the Week: Yuval Diskin
You Can’t Taper a Ponzi Scheme: Time to Reboot
Losing the Moral High Ground
Thank You for Your Service: How One Company Sues Soldiers Worldwide
sign up to get updates
By Norman G. Finkelstein
A New Jersey drug company says Bremolanotide, which stimulates the brain, rather than the genitals, may be the long-sought female version of Viagra. The drug is still in preclinical tests.
PT-141, a nasal spray that is perhaps the world’s first legitimate aphrodisiac, may hit the market in under three years. The Observer wonders whether such a “sure thing” will trivialize the emotional aspect of relationships.
View the most popular tags overall?